Scientific Program

Preliminary Schedule

(Subject to change)

Thursday, September 17, 2026

8:00 – 9: 00	Registration & Breakfast
Session-1 9:00 – 10:15
9:00 – 9:15	Welcome and Opening Remarks – Adrian Budhram, MD
9:15 – 10: 15	Keynote Address: Improving Diagnostic Performance in Neural Antibody Testing Through Harmonization – John R. Mills, PhD; Co-director of Mayo Clinic Neuroimmunology Laboratory
10: 15 – 10: 30	Coffee Break
Session-2 10:30 – 12:00
10:30-11:15	Autoantibody testing in NMOSD/MOGAD: Insights from CANOPTICS – Dalia Rotstein, MD MPH
11:15-12:00	Autoantibody testing and clinical decision-making in autoimmune encephalitis – Alexandra Muccilli, MD MEd
12:00 – 12:15	Autoantibody Summit 2026 Group Picture
12:15 – 13:30	Lunch
Session-3 13:30 – 15:00	Sponsored Session
13:30 – 14:15	Autoantibody testing and Neurology – TBA
14:15 – 15:00	Diagnosis and management of CIDP versus autoantibody-associated mimickers – Anita Florendo-Cumbermack, MBBS, MHPE
15:00 – 15:15	Coffee Break
Session-4 15:15 – 16:45
15:15 – 16:00	Autoantibody testing for myasthenia gravis: A laboratory perspective – Kareena Schnabl, PhD
16:00 – 16:45	“Clinical correlation required”: Facilitating clinical-serological correlation of neural antibody test results – Adrian Budhram, MD
16:45 – 18:30	Social Event
18:30 – 21:00	Dinner Event & AAN Activities (Recognition & Invitation to Autoantibody Summit 2027)

Friday, September 18, 2026

8:00 – 9: 00	Registration & Breakfast
Session-5 9:00 – 10:30
9:00-9:45	Use and misuse of autoantibody testing in suspected inflammatory arthropathies – Tom Appleton, MD, PhD
9:45-10:30	Clinical utility of autoantibody testing in systemic sclerosis – Janet Pope, MD, MPH
10:30 – 10:45	Coffee Break
Session-6 10:45 – 12:15
10:45 – 11:30	Diagnosis and management of IgG4-related disease – Gideon Hirschfield, MB BChir, PhD
11:30 – 12:15	Clinical utility of antibody testing in autoimmune hematologic diseases – Cyrus Hsia, MD
12:15 – 13:30	Lunch
Session-7 13:30 – 14:45	Sponsored Session
13:30 – 14:15	Myositis: An Overview of Disease and Associated Antibodies – Sam Siporin, BS
14:15 – 14:45	Anti-Mutated Citrullinated Vimentin (Anti-MCV) Antibodies in Rheumatoid Arthritis: Clinical Utility and Healthcare System Impact - Oliver Sendscheid, PhD
14:45 – 15:00	Coffee Break
Session-8 15:00 – 16:30
15:00-15:45	Autoantibody testing in pediatric rheumatology practice: Access, indications, and implications – Tania Cellucci, MD, MScCH
15:45-16:30	Antinuclear antibody testing: optimizing test algorithms and utilization – Mary Kathryn Bohn, PhD
16:30 – 16:45	Closing Remarks - Adrian Budhram, MD
16:45 –	Departure from the Conference